Connection
Shuk-Mei Ho to Carcinoma, Hepatocellular
This is a "connection" page, showing publications Shuk-Mei Ho has written about Carcinoma, Hepatocellular.
|
|
Connection Strength |
|
|
|
|
|
0.274 |
|
|
|
-
Leung YK, Lee SG, Wang J, Guruvaiah P, Rusch NJ, Ho SM, Park C, Kim K. The Loss of an Orphan Nuclear Receptor NR2E3 Augments Wnt/?-catenin Signaling via Epigenetic Dysregulation that Enhances Sp1-? catenin-p300 Interactions in Hepatocellular Carcinoma. Adv Sci (Weinh). 2024 Aug; 11(29):e2308539.
Score: 0.196
-
Zhou Q, Ching AK, Leung WK, Szeto CY, Ho SM, Chan PK, Yuan YF, Lai PB, Yeo W, Wong N. Novel therapeutic potential in targeting microtubules by nanoparticle albumin-bound paclitaxel in hepatocellular carcinoma. Int J Oncol. 2011 Mar; 38(3):721-31.
Score: 0.078